Skip to main content

Table 1 Patient characteristics

From: Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders

Variables

n

Mean ± SD or %

Age (years)

473

80.58 ± 7.48

Gender

 Female

291

61.52%

 Male

182

38.48%

Educational level

 Middle school without certificate

73

15.43%

 Middle school with certificate

174

36.79%

 High school

150

31.71%

 University/college

76

16.07%

Current lifestyle

 At home with husband/spouse

273

57.72%

 At home with relatives

29

6.13%

 At home, alone, with relatives in the neighborhood

119

25.16%

 At home, alone, without relatives in the neighborhood

30

6.34%

 Other lifestyle

22

4.65%

Number of drugs

473

5.27 ± 2.57

Diagnostic stage

 Subjective cognitive impairment

123

26.00%

 Mild neurocognitive disorder

131

27.70%

 Major neurocognitive disorder

219

46.30%

Diagnostic etiology

 Alzheimer’s disease

160

33.83%

 Alzheimer’s disease with cardiovascular component

30

6.34%

 Vascular dementia

29

6.13%

 Lewy body disease

8

1.69%

 Fronto temporal dementia

5

1.06%

 Other dementia

8

1.69%

 Parkinson’s disease

8

1.69%

 Psychiatric disorders

37

7.82%

 Others disorders

17

3.59%

 Diagnostic not yet established

171

36.15%

Comorbidities

 Hypertension

192

40.60%

 Diabetes mellitus

53

11.21%

 Hypercholesterolemia

79

16.70%

MMSE

 >20 (mild)

241

50.95%

 10–20 (moderate)

181

38.27%

 <10 (severe)

26

5.50%

Characteristics considered as continuous scores

 MMSE

448

20.02 ± 6.29

 IADL

469

3.60 ± 2.45

 NPI

410

18.27 ± 13.40

  1. MMSE Mini Mental State Examination, IADL Instrumental Activities of Daily Living, NPI Neuropsychiatric Inventory